BSX · News · 20260804N

Competition and Market Share

BOSTON SCIENTIFIC CORP · 2026-08-04 · Importance 26 · Surprise 24

Third-party analysis cited share losses for Boston Scientific in electrophysiology (EP), indicating competitive pressure in cardiac rhythm procedures. The commentary also identified weakness in the WATCHMAN device franchise, which is used for left atrial appendage closure. Medtronic’s Affera mapping and ablation system with the Sphere-9 catheter received a European CE-mark expansion for ventricular arrhythmia treatment, potentially increasing competition in EP ablation.

Key facts